NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
- NHS England
Procurement identifier (OCID): ocds-h6vhtk-05936a
Description
Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026
Offer reference number: CM/TNS/25/5735
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months)
Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months)
Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Notices
UK4: Tender notice
- Notice identifier
- 2025/S 000-061712
- Published
- 2 October 2025, 1:32pm
UK2: Preliminary market engagement notice
- Notice identifier
- 2025/S 000-053638
- Published
- 3 September 2025, 3:37pm